Russell Martin’s deal is backloaded. So too is Giancarlo Stanton’s. REALLY backloaded. As in, he’ll only make $30 million in his first three years. And, if he opts out after the first six years of his 13-year deal, he leaves $218 million on the table. The details from Jayson Stark:
According to a major league source who had seen the terms, Stanton’s salaries over those first three seasons will be only $6.5 million in 2015, $9 million in 2016 and $14.5 million in 2017, far less than he could have earned through arbitration in 2015-16 and then via free agency. He would then earn $77 million over the next three seasons, and could opt out of the contract after 2020, following his age 30 season.
So the Marlins would be on the hook for only $107 million of the deal over the first six seasons, which computes to an average annual value of just $17.83 million per season before Stanton would have the right to exercise the opt-out clause.
This certainly changes the view of this deal. And if for some reason this deal turns sour on the Marlins, it turns really sour, with the final seven years coming in at over $31 million a year all while Stanton has a full no-trade clause. One big injury or some inexplicable Dale Murphy-style falloff and it’s uglyville.
In the meantime, though: a bargain for the Marlins and flexibility for them to go get other pieces to complement Stanton. Now: will they do it?
Ken Rosenthal of The Athletic reported last night that Major League Baseball is “actively pursuing an additional medical lab site to increase the speed and efficiency” of MLB COVID-19 tests.
The current setup — as planned by MLB and approved by the MLBPA as a part of the plan to play the 2020 season — is for all MLB COVID-19 tests to be sent to and processed by MLB’s PED testing lab in Salt Lake City, Utah. As you likely heard, there have been delays in the administration of COVID-19 tests and in the shipping of tests to Utah, but to date no one has reported that the lab itself has not been able to handle the tests once they’ve arrived there. If MLB is looking for a second lab site a week into this process, it suggests that their plans for the Utah lab might not be working the way they had anticipated.
The issues with testing have created unease around the game in recent days, with some players and team executives speaking out against Major League Baseball’s handling of the plan in the early going. Commissioner Rob Manfred, meanwhile, has responded defensively to the criticism.
Meanwhile, the New York Times reported this morning that, months into the COVID-19 pandemic, the United States still lacks testing capacity. From the report:
Lines for coronavirus tests have stretched around city blocks and tests ran out altogether in at least one site on Monday, new evidence that the country is still struggling to create a sufficient testing system months into its battle with Covid-19 . . .“It’s terrifying, and clearly an evidence of a failure of the system,” said Dr. Morgan Katz, an infectious disease expert at Johns Hopkins Hospital . . . in recent weeks, as cases have surged in many states, the demand for testing has soared, surpassing capacity and creating a new testing crisis.
It’s less than obvious, to say the least, how Major League Baseball plans to expand capacity for MLB COVID-19 tests while America as a whole is experiencing “a new testing crisis” and a “failure of the system.” At the very least it’s less than obvious how, even if Major League Baseball can do so, it can do so ethically.